Merck (MRK) EV to EBITDA (2009 - 2026)

Merck (MRK) has reported EV to EBITDA for 18 consecutive years, with 530.72 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to EBITDA fell 1500.52% year-over-year to 530.72 in Q2 2026; TTM through Jun 2026 was 30.64, a 209.14% increase from a year earlier, with the FY2025 full-year figure at 11.58, down 2.97% from the prior year.
• EV to EBITDA was 530.72 for Q2 2026 at Merck, down from 85.82 in the prior quarter.
• Over five years, EV to EBITDA peaked at 124.63 in Q4 2023 and troughed at 530.72 in Q2 2026.
• A 5-year average of 8.09 and a median of 44.37 in 2022 frame the typical range for EV to EBITDA.
• Across the five-year window, EV to EBITDA soared 190.15% in 2024 and slumped 1500.52% in 2026, its largest moves.
• Over 5 years, EV to EBITDA stood at 78.11 in 2022, then soared by 59.56% to 124.63 in 2023, then slumped by 55.62% to 55.31 in 2024, then plunged by 41.45% to 32.38 in 2025, then plunged by 1738.81% to 530.72 in 2026.
• The last three EV to EBITDA figures came in at 530.72 (Q2 2026), 85.82 (Q1 2026), and 32.38 (Q4 2025), per Business Quant data.